FindTrial
Sign In

Selective Sympathetic Action on Heart Rate Variability after Ultrasound-guided Stellate Ganglion Block

Selective Sympathetic Action on Heart Rate Variability after Ultrasound-guided Stellate Ganglion Block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033575
Enrollment
12
Registered
2024-02-16
Start date
2016-08-15
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Selective Sympathetic Action on Heart Rate Variability after Ultrasound-guided Stellate Ganglion Block

Interventions

Group 1: 3 ml ropivacaine 1 % (verum), The first recording of the time- and frequency-dependent HRV parameters took place before the application over 5 minutes (pre-value). After the application, the

Sponsors

Universitätsklinikum Mannheim
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: -Male -18 to 80 years

Exclusion criteria

Exclusion criteria: -Minors are excluded from the study -females and incapacitated adults -Patients who do not fulfil the above inclusion criteria or who do not give their consent for inclusion in the study must also be excluded. -rhythm disturbance -Medication that affects the autonomic nervous system -Cardiac pacemaker

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the selectiv block of efferent sympathetic fibres to the heart and upper extremity via an ultrasound-guided SGB technique—

Secondary

MeasureTime frame
The secodary endpoint is the missing effekt of the ultrasound-guided SGB technique on vagal tone—

Countries

Germany

Contacts

Public ContactJustus Benrath

Klinik für Anästhesiologie und Operative Intensivmedizin

Justus.Benrath@umm.de0496213832608

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026